Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
2
currently held
Exits tracked
1
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin3 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Aurka Pharma, Inc. TVM Life Science Ventures | TVM Capital Life Science | 2016 | 3yr | Exited 2019 | Eli Lilly | – | |||
Corealis MED Platform II | ARCHIMED | 2022 | 4yr | Active | – | – | |||
Searchlight Pharma Inc. Crédit Mutuel Equity | Crédit Mutuel Equity | 2017 | 9yr | Active | – | – |
Aurka Pharma, Inc.
TVM Life Science Ventures
Canada
Sector
Pharma
InvestorTVM Capital Life Science
Entry
2016
Hold
3yr
Exit
2019
to Eli Lilly
Corealis
MED Platform II
Canada
Sector
Pharma
InvestorARCHIMED
Entry
2022
Hold
4yr
Searchlight Pharma Inc.
Crédit Mutuel Equity
Canada
Sector
Pharma
InvestorCrédit Mutuel Equity
Entry
2017
Hold
9yr